Erschienen in:
26.06.2020 | Case Report
Infliximab use for corticosteroid-resistant tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in an immunocompetent patient
verfasst von:
Deborah Eshagh, Khadija Benali, Antoine Dossier, Marie Paule Chauveheid, Diane Rouzaud, Tiphaine Goulenok, Thomas Papo, Karim Sacre
Erschienen in:
Infection
|
Ausgabe 5/2020
Einloggen, um Zugang zu erhalten
Abstract
In non-human immunodeficiency virus (HIV)-infected patients, tuberculosis (TB) immune reconstitution inflammatory syndrome (IRIS) is unusual. The management of corticosteroids-refractory IRIS is unclear. We report on infliximab efficacy for treatment of corticosteroid-resistant TB-IRIS occurring in an immunocompetent patient.